Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

被引：0
|
作者：
Yusuke Kurita
Jun Araya
Shunsuke Minagawa
Hiromichi Hara
Akihiro Ichikawa
Nayuta Saito
Tsukasa Kadota
Kazuya Tsubouchi
Nahoko Sato
Masahiro Yoshida
Kenji Kobayashi
Saburo Ito
Yu Fujita
Hirofumi Utsumi
Haruhiko Yanagisawa
Mitsuo Hashimoto
Hiroshi Wakui
Yutaka Yoshii
Takeo Ishikawa
Takanori Numata
Yumi Kaneko
Hisatoshi Asano
Makoto Yamashita
Makoto Odaka
Toshiaki Morikawa
Katsutoshi Nakayama
Kazuyoshi Kuwano
机构：
[1] Jikei University School of Medicine,Division of Respiratory Diseases, Department of Internal Medicine
[2] Graduate School of Medical Sciences,Research Institute for Diseases of the Chest
[3] Kyushu University,Department of Respiratory Medicine
[4] Faculty of Life Science,Division of Chest Diseases; Department of Surgery
[5] Kumamoto University,undefined
[6] Jikei University School of Medicine,undefined
来源：
Respiratory Research | / 18卷
关键词：
Autophagy; IPF; Myofibroblast; Mitophagy; Pirfenidone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 23 条
  • [21] Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway
    Zuo, Yanhua
    Liu, Jing
    Xu, Huaheng
    Li, Yanxia
    Tao, Ran
    Zhang, Zongfang
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 2089 - 2102
  • [22] Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer
    Zhang, Shuling
    Wang, Yuanmei
    Luo, Daiqin
    Cheng, Zhimei
    Zeng, Qibing
    Wang, Guoze
    Chen, Mengxue
    Zhang, Shuai
    Luo, Peng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [23] Role of Fibroblast Growth Factor 10 in Mesenchymal Cell Differentiation During Lung Development and Disease
    Wu, Jin
    Chu, Xuran
    Chen, Chengshui
    Bellusci, Saverio
    FRONTIERS IN GENETICS, 2018, 9
123